Related Experiment Video
Updated: Aug 6, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
[Prevention of cardiovascular complications after a stroke or TIA: hypotensive and hypocholesterolemic therapy]
1Erasmus Medisch Centrum, afd. Neurologie, Postbus 1738, 3000 DR Rotterdam. d.dippel@erasmusmc.nl
Insights
Reducing cholesterol and blood pressure significantly lowers cardiovascular disease risk in TIA or stroke patients. Further trials will clarify effectiveness in elderly patients and optimal simvastatin dosages.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Context:
- Patients with recent TIA or stroke face high risks of recurrent cardiovascular events.
- Randomized clinical trials have established the benefits of lipid-lowering and blood pressure reduction.
Purpose:
- To review the evidence for pharmacological interventions in secondary prevention after TIA or stroke.
- To identify areas requiring further research, such as treatment in elderly patients and optimal drug regimens.
Summary:
- Cholesterol-lowering treatment is effective for TIA/stroke patients with total cholesterol ≥ 3.5 mmol/l.
- Antihypertensive therapy, initiated with diuretics, effectively prevents recurrent stroke and myocardial infarction.
- Further studies are needed to assess cholesterol-lowering efficacy in patients over 80 and with minor strokes, and to determine optimal simvastatin doses.
Impact:
- Provides evidence-based recommendations for secondary cardiovascular prevention in TIA/stroke survivors.
- Highlights the need for individualized treatment approaches, especially in elderly patients or those with normal/mildly elevated blood pressure.
- Informs clinical practice regarding the management of cholesterol and blood pressure to reduce recurrent vascular events.
Abstract:
In patients who have recently had a TIA or stroke, the risk of new serious cardiovascular disease is decreased by the pharmacological reduction of the serum cholesterol level and blood pressure; this has been convincingly demonstrated by randomised clinical trials. There is sufficient evidence that cholesterol-lowering treatment is effective in patients with a TIA or cerebral infarction who have a total cholesterol > or = 3.5 mmol/l. The results from a trial in patients with only a TIA or a minor stroke will have to answer the question whether cholesterol-lowering treatment will be effective in patients > 80 years, and whether higher dosages of simvastatin will be more effective in these patients. Antihypertensive therapy is effective in preventing recurrent stroke and myocardial infarction in patients with a recent stroke or TIA. It is obvious that the treatment should be started with a diuretic and that a second agent should be added if necessary. On epidemiological grounds, vigorous treatment is also justified in patients with a normal or mildly elevated blood pressure; caution and a custom-tailored approach are essential, however, in each individual patient.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Transient Ischemic Attack l: Introduction

